Premium
Coronary stenting in diabetics: Immediate and mid‐term clinical outcome
Author(s) -
Joseph Thierry,
Fajadet Jean,
Jordan Christian,
Cassagneau Bernard,
Laborde JeanClaude,
Laurent JeanPierre,
Marco Jean
Publication year - 1999
Publication title -
catheterization and cardiovascular interventions
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.988
H-Index - 116
eISSN - 1522-726X
pISSN - 1522-1946
DOI - 10.1002/(sici)1522-726x(199907)47:3<279::aid-ccd3>3.0.co;2-p
Subject(s) - medicine , myocardial infarction , diabetes mellitus , cardiology , angioplasty , insulin , restenosis , thrombosis , surgery , population , revascularization , stent , endocrinology , environmental health
Balloon angioplasty in diabetics is associated with acceptable immediate results but with high rates of restenosis, target vessel revascularization, and late mortality. The impact of coronary stenting on the outcome of these patients remains controversial. We reported the immediate and mid‐term clinical outcome of 272 consecutive diabetic patients, representing 12.5% of the population undergoing coronary stenting between May 1995 and April 1997. Diabetes mellitus was insulin‐requiring in 58 patients and non–insulin‐requiring in 214. Stenting performed on large vessels (mean diameter ≥3 mm) was successful in 99.2% of nondiabetic patients and in all cases in diabetics. During in‐hospital stay, the complications rate, including mortality, nonfatal myocardial infarction, emergency coronary bypass surgery, and stent subacute thrombosis, was similar in nondiabetic patients, insulin‐requiring, and non–insulin‐requiring diabetics (2.55%, 0%, and 2.0%, respectively). No complication occurred in the insulin‐requiring group. One patient (0.5%) died from myocardial infarction and another (0.5%) presented a nonfatal myocardial infarction (subacute stent thrombosis) in the non–insulin‐requiring group. The clinical follow‐up (mean length 13 ± 8 months) was obtained in 93% and 97% of the insulin‐requiring and non–insulin‐requiring diabetics, respectively. Overall mortality was significantly higher in insulin‐requiring patients (9.3% vs. 2.4%). Nonfatal myocardial infarction and target lesion revascularization rates were similar in the two groups (0% vs. 0.5% and 8.2% vs. 10.5%). These results suggest that coronary stenting in diabetics could be performed with acceptable immediate and mid‐term results. Cathet. Cardiovasc. Intervent. 47:279–284, 1999. © 1999 Wiley‐Liss, Inc.